Researchers from Hannover, Germany, have developed a liquid chromatography–tandem mass spectrometry (LC–MS/MS) multi-target screening strategy for use in ante-mortem and post-mortem rodenticide analysis in forensic toxicology (1).
Rodenticides are a commonly used method of controlling rodent populations. However, these substances also pose significant risk to domestic animals such as cats and dogs because secondary poisoning might occur if the baited traps or poisoned rodent is ingested. Furthermore, human poisoning with rodenticides does occur and a reliable and convenient identification methodology for the relevant substances is essential for forensic toxicology laboratories.
There are numerous classes of rodenticides and their analysis is performed predominately using LC–MS/MS. While these methods are successful, they only focus on rodenticides and do not allow the simultaneous identification of other substances, which is useful for confirming a suspected rodenticide poisoning but not as useful if the case history is unclear and a wider forensic toxicology net is required. Additionally, a common issue encountered in forensic toxicology is a lack of the relevant analytical material available, which can make the use of multiple investigatory analyses unviable. Therefore, a method that can reduce the number of required analyses and cover the most important substances in relevant concentration ranges is required.
In this paper, researchers aimed to develop a multi-target screening strategy based on a simple and fast sample preparation step and test it by investigating real cases of rodenticide toxications in animals. The developed method utilized a simple protein precipitation step for sample preparation and LC–MS/MS, targeting multiple rodenticides, including: α-chloralose, brodifacoum, bromadiolone, coumatetralyl, difenacoum, and warfarin. In total, around 250 substances are covered by the method, which was validated to ensure the substances could be identified at low concentration ranges. Further to the rodenticides, the method was also capable of identifying common drugs regularly screened for in forensic toxicology.
While the method was developed for human plasma and post-mortem blood, it can also be utilized for animal testing, with real animal samples from dogs and cats suspected of eating rodenticide baits being investigated. In the processed cases, all rodenticides were identified except for bromadiolone.
The presented method offered several advantages over current analytical procedures, and the researchers believe there is scope for future development of the method with the incorporation of rodenticide-related metabolites, which could give additional information and help in the interpretation of investigated intoxications.
Reference
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.